Skip to main content
OpenTrials

Clinical trial condition

Neoplasms, Plasma Cell

Explore clinical trials studying Neoplasms, Plasma Cell. Study availability and eligibility vary by location and protocol.

2,604 public trials 547 recruiting studies
Refine in advanced search Browse all conditions

Neoplasms, Plasma Cell trial results

Completed

Efficacy of Panobinostat in Patients With Relapsed and Bortezomib-refractory Multiple Myeloma

NCT01083602

Conditions
Blood Protein Disorders, Cardiovascular Diseases, Disease Attributes, +19 more
Locations
  • University of California at Los Angeles Los Angeles, California, United States
  • Stanford University Medical Center Division of Hematology Stanford, California, United States
  • H. Lee Moffitt Cancer Center & Research Institute Tampa, Florida, United States
  • Emory University School of Medicine/Winship Cancer Institute Dept. of Winship Cancer Inst. Atlanta, Georgia, United States
View all 13 locations
View Trial Details
Completed

Phase 2 Clinical Trial of NPI-0052 in Patients With Relapsed or Relapsed/Refractory Multiple Myeloma

NCT00461045

Conditions
Blood Protein Disorders, Cardiovascular Diseases, Disease Attributes, +16 more
Locations
  • Moffitt Cancer Center Tampa, Florida, United States
  • University of Chicago, School of Medicine Chicago, Illinois, United States
  • University of Maryland Baltimore, Maryland, United States
  • Dana Farber Cancer Institute Boston, Massachusetts, United States
View Trial Details
Completed

A Study to Collect and Evaluate the Safety and Efficacy Information of Korean Multiple Myeloma Patients Treated With REVLIMID®, After Approval of Marketing Authorization for New Drug in Korea

NCT02556905

Conditions
Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +12 more
Locations
  • Hallym University Sacred Heart Hospital Anyang, South Korea
  • Soon Chun Hyang University Hospital Bucheon Bucheon-si, South Korea
  • Inje University Busan Paik Hospital Busan, South Korea
  • Inje University Haeundae Paik Hospital Busan, South Korea
View all 25 locations
View Trial Details

Related conditions